Financings Roundup

Shaffer, Catherine
March 2013
BioWorld Today;3/27/2013, Vol. 24 Issue 58, p4
The article reports that Medgenics Inc. of San Francisco, California said that underwriters exercised an option to purchase stock in its public offering in 2013.


Related Articles

  • Financings Roundup.  // BioWorld Today;4/21/2011, Vol. 22 Issue 77, p4 

    This article reports on the move of underwriters of a U.S. initial public offering (IPO) issued by Medgenics Inc. to exercise their option to purchase additional warrants to purchase 369,000 shares of common stock.

  • Corrections & Clarifications.  // BioWorld Today;12/6/2007, Vol. 18 Issue 236, p2 

    A correction to the article about the initial public offering of Medgenics Inc. is presented.

  • Financings Roundup.  // BioWorld Today;4/11/2011, Vol. 22 Issue 69, p4 

    The article reports that Misgav, Israel-based Medgenics Inc. has priced its initial public offering in the U.S. of 2.46 million shares of common stock at 4.54 U.S. dollars per share and redeemable common stock purchase warrants at 46 cents per warrant.

  • Is Underpricing an Appropriate Proxy for Studying IPO Certification? Hopkins, Mike; Ross, Donald G. // International Journal of Economics & Finance;May2014, Vol. 6 Issue 5, p117 

    The dominant technique used to evidence certification effects at IPO is to employ the degree of underpricing as a proxy for certification. We investigate the appropriateness of this proxy in the context of private equity backed IPOs. Our results reveal an incongruence between certification by...

  • Medgenics' IPO Pulls £3.28M To Advance Biopump Efforts. Osborne, Randall // BioWorld Today;11/30/2007, Vol. 18 Issue 232, p1 

    The article reports that the funds raised by the initial public offering (IPO) of Medgenics Inc. in Great Britain has positioned the company to test its Biopump drug-device combo method for delivering erythropoietin in Phase I/II trials by the middle of 2008. The firm was able to sell about 104...

  • Purchasing IPOs with Commissions. Goldstein, Michael A.; Irvine, Paul; Puckett, Andy // Journal of Financial & Quantitative Analysis;Sep2011, Vol. 46 Issue 5, p1193 

    We find direct evidence that institutions increase round-trip stock trades, increase average commissions per share, and pay unusually high commissions on some trades in order to send abnormally high commissions to the lead underwriters of profitable initial public offerings (IPOs). These excess...

  • Meeting of the Minds. Maisami, Ceyda A.; McDonell, Leslie A. // Landslide;May/Jun2012, Vol. 4 Issue 5, p54 

    The article analyzes the effects of patent portfolios on the initial public offering (IPO) market. Several factors can be considered as predictors of IPO pricing, including venture capital backing, underwriter standing, size and age of the business, chief executive officer (CEO) equity and...

  • Facebook Adds 25 More Underwriters. Platt, Gordon // Global Finance;Apr2012, Vol. 26 Issue 4, p88 

    The article reports on the move of Facebook Inc. to add 25 underwriters as the firm prepares for its initial public offering (IPO) which aimed to raise 10 billion dollars, valuing the social networking company at 100 billion dollars. It mentions that Facebook Inc. has selected Morgan Stanley &...

  • Does the Gross Spread Compensate Lead Underwriters for Analyst Coverage? Cheolwoo Lee // Accounting & Finance Research;Nov2012, Vol. 1 Issue 2, p36 

    Since underpricing and gross spread are the two main revenue sources for investment banks in public offerings and Cliff and Denis (2004) find that underpricing is used to compensate analyst coverage, this paper examines the IPO syndicate data to investigate whether the gross spread compensates...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics